N-(1-METHYL-5-INDOLYL)-N'-(3-METHYL-5-ISOTHIAZOLYL)UREA - A NOVEL, HIGH-AFFINITY 5-HT2B RECEPTOR ANTAGONIST

被引：68
|
作者：
FORBES, IT
JONES, GE
MURPHY, OE
HOLLAND, V
BAXTER, GS
机构：
[1] SMITHKLINE BEECHAM PHARMACEUT,DEPT NEUROL,HARLOW CM19 5AW,ESSEX,ENGLAND
[2] SMITHKLINE BEECHAM PHARMACEUT,DEPT PSYCHIAT,HARLOW CM19 5AW,ESSEX,ENGLAND
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 1995年 / 38卷 / 06期
关键词：
D O I：
10.1021/jm00006a001
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
[No abstract available]
引用
收藏
页码：855 / 857
页数：3
相关论文
共 50 条
  • [1] N-(1-METHYL-5-INDOLYL)-N'-(3-PYRIDYL)UREA HYDROCHLORIDE - THE 1ST SELECTIVE 5-HT(1C) RECEPTOR ANTAGONIST
    FORBES, IT
    KENNETT, GA
    GADRE, A
    HAM, P
    HAYWARD, CJ
    MARTIN, RT
    THOMPSON, M
    WOOD, MD
    BAXTER, GS
    GLEN, A
    MURPHY, OE
    STEWART, BA
    BLACKBURN, TP
    JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (08) : 1104 - 1107
  • [2] RS-127445: A selective, high-affinity, orally bioavailable 5-HT2B receptor antagonist.
    Flippin, LA
    Bonhaus, DW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U971 - U971
  • [3] A selective, high affinity 5-HT2B receptor antagonist inhibits visceral hypersensitivity in rats
    Ohashi-Doi, K.
    Himaki, D.
    Nagao, K.
    Kawai, M.
    Gale, J. D.
    Furness, J. B.
    Kurebayashi, Y.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2010, 22 (02): : e69 - e76
  • [4] 5-METHYL-1-(3-PYRIDYLCARBAMOYL)-1,2,3,5-TETRAHYDROPYRROLO[2,3-F]INDOLE - A NOVEL 5-HT2C 5-HT2B RECEPTOR ANTAGONIST WITH IMPROVED AFFINITY, SELECTIVITY, AND ORAL ACTIVITY
    FORBES, IT
    HAM, P
    BOOTH, DH
    MARTIN, RT
    THOMPSON, M
    BAXTER, GS
    BLACKBURN, TP
    GLEN, A
    KENNETT, GA
    WOOD, MD
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (14) : 2524 - 2530
  • [5] Characterization of a novel, high-affinity and selective fluorescent antagonist for the 5HT1A receptor
    Fatokun, Amos Akintayo
    Middleton, Richard J.
    Thompson, Kevin S. J.
    Briddon, Stephen J.
    Hill, Stephen J.
    FASEB JOURNAL, 2013, 27
  • [6] RS-127445:: a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist
    Bonhaus, DW
    Flippin, LA
    Greenhouse, RJ
    Jaime, S
    Rocha, C
    Dawson, M
    Van Natta, K
    Chang, LK
    Pulido-Rios, T
    Webber, A
    Leung, E
    Eglen, RM
    Martin, GR
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 127 (05) : 1075 - 1082
  • [7] N-(QUINUCLIDIN-3-YL)-2-(1-METHYL-1H-INDOL-3-YL)-2-OXOACETAMIDE - A HIGH-AFFINITY 5-HT3 RECEPTOR PARTIAL AGONIST
    CLARK, RD
    MUCHOWSKI, JM
    WEINHARDT, KK
    DILLON, MP
    LEE, CH
    BLEY, KR
    BONHAUS, DW
    WONG, EHF
    EGLEN, RM
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (16) : 1853 - 1856
  • [8] [H-3] 5-METHYL-URAPIDIL BINDS WITH HIGH-AFFINITY TO SEROTONIN RECEPTORS OF THE 5-HT1A SUBTYPE
    SCHUTTLER, K
    GROSS, G
    XIN, X
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (03) : 1108 - 1108
  • [9] N-4-UNSUBSTITUTED N-1-ARYLPIPERAZINES AS HIGH-AFFINITY 5-HT1A RECEPTOR LIGANDS
    KUIPERS, W
    VANWIJNGAARDEN, I
    KRUSE, CG
    TERHORSTVANAMSTEL, M
    TULP, MTM
    IJZERMAN, AP
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (11) : 1942 - 1954
  • [10] (-)-5-methyl-8-hydroxy-(di-n-propylamino)tetralin:: A new 5-HT1A receptor antagonist
    Trillat, AC
    Mathé-Allainmat, M
    Brémont, B
    Malagié, I
    Jacquot, C
    Gardier, AM
    Langlois, M
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1998, 33 (06) : 437 - 444
12345